1. Home
  2. FUN vs NNNN Comparison

FUN vs NNNN Comparison

Compare FUN & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cedar Fair L.P.

FUN

Cedar Fair L.P.

HOLD

Current Price

$15.93

Market Cap

1.5B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$24.60

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUN
NNNN
Founded
1983
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
1987
2025

Fundamental Metrics

Financial Performance
Metric
FUN
NNNN
Price
$15.93
$24.60
Analyst Decision
Buy
Analyst Count
13
0
Target Price
$27.31
N/A
AVG Volume (30 Days)
2.6M
88.1K
Earning Date
02-19-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
$3,137,510,000.00
$6,920,153.00
Revenue This Year
$13.96
N/A
Revenue Next Year
$4.60
N/A
P/E Ratio
N/A
$412.64
Revenue Growth
31.13
N/A
52 Week Low
$12.51
$5.18
52 Week High
$48.80
$55.65

Technical Indicators

Market Signals
Indicator
FUN
NNNN
Relative Strength Index (RSI) 42.10 45.58
Support Level $16.93 $21.09
Resistance Level $18.92 $28.00
Average True Range (ATR) 1.10 6.58
MACD -0.26 0.16
Stochastic Oscillator 1.84 21.97

Price Performance

Historical Comparison
FUN
NNNN

About FUN Cedar Fair L.P.

Six Flags Entertainment Corp is North America's regional amusement resort operator with approximately 27 amusement parks, around 15 separately gated water parks, and nine resort properties across the U.S., Canada, and Mexico. It provides coasters, themed rides, thrilling water parks, resorts, and a portfolio of beloved intellectual properties such as Looney Tunes, DC Comics, and PEANUTS.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: